Sulindac inhibits beta-catenin expression in normal-appearing colon of hereditary nonpolyposis colorectal cancer and familial adenomatous polyposis patients

J.J. Koornstra; F.E. Rijcken; C.N. Oldenhuis; N. Zwart; T. van der Sluis; H. Hollema; E.G. de Vries; J.J. Keller; G.J.A. Offerhaus; F.M. Giardiello; J.H. Kleibeuker

Sulindac inhibits beta-catenin expression in normal-appearing colon of hereditary nonpolyposis colorectal cancer and familial adenomatous polyposis patients

Translated title of the contribution: Sulindac inhibits beta-catenin expression in normal-appearing colon of hereditary nonpolyposis colorectal cancer and familial adenomatous polyposis patients

J.J. Koornstra
, F.E. Rijcken
, C.N. Oldenhuis
, N. Zwart
, T. van der Sluis
, H. Hollema
, E.G. de Vries
, J.J. Keller
, G.J.A. Offerhaus
, F.M. Giardiello
, J.H. Kleibeuker

Department of Pathology

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Sulindac inhibits beta-catenin expression in normal-appearing colon of hereditary nonpolyposis colorectal cancer and familial adenomatous polyposis patients
Original language	Undefined/Unknown
Pages (from-to)	1608-1612
Number of pages	5
Journal	Cancer Epidemiology Biomarkers & Prevention
Volume	14
Issue number	7
Publication status	Published - 2005

Keywords

Econometric and Statistical Methods: General
Geneeskunde (GENK)
Geneeskunde(GENK)
Algemeen onderzoek
Internal medicine

Cite this

Koornstra, J. J., Rijcken, F. E., Oldenhuis, C. N., Zwart, N., van der Sluis, T., Hollema, H., de Vries, E. G., Keller, J. J., Offerhaus, G. J. A., Giardiello, F. M., & Kleibeuker, J. H. (2005). Sulindac inhibits beta-catenin expression in normal-appearing colon of hereditary nonpolyposis colorectal cancer and familial adenomatous polyposis patients. Cancer Epidemiology Biomarkers & Prevention, 14(7), 1608-1612.

@article{a307f9690883462aa63c4cea73ccb5b5,

title = "Sulindac inhibits beta-catenin expression in normal-appearing colon of hereditary nonpolyposis colorectal cancer and familial adenomatous polyposis patients",

keywords = "Econometric and Statistical Methods: General, Geneeskunde (GENK), Geneeskunde(GENK), Algemeen onderzoek, Internal medicine",

author = "J.J. Koornstra and F.E. Rijcken and C.N. Oldenhuis and N. Zwart and \{van der Sluis\}, T. and H. Hollema and \{de Vries\}, E.G. and J.J. Keller and G.J.A. Offerhaus and F.M. Giardiello and J.H. Kleibeuker",

year = "2005",

language = "Undefined/Unknown",

volume = "14",

pages = "1608--1612",

journal = "Cancer Epidemiology Biomarkers \& Prevention",

issn = "1055-9965",

publisher = "American Association for Cancer Research Inc.",

number = "7",

}

Koornstra, JJ, Rijcken, FE, Oldenhuis, CN, Zwart, N, van der Sluis, T, Hollema, H, de Vries, EG, Keller, JJ, Offerhaus, GJA, Giardiello, FM & Kleibeuker, JH 2005, 'Sulindac inhibits beta-catenin expression in normal-appearing colon of hereditary nonpolyposis colorectal cancer and familial adenomatous polyposis patients', Cancer Epidemiology Biomarkers & Prevention, vol. 14, no. 7, pp. 1608-1612.

Sulindac inhibits beta-catenin expression in normal-appearing colon of hereditary nonpolyposis colorectal cancer and familial adenomatous polyposis patients. / Koornstra, J.J.; Rijcken, F.E.; Oldenhuis, C.N. et al.
In: Cancer Epidemiology Biomarkers & Prevention, Vol. 14, No. 7, 2005, p. 1608-1612.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Sulindac inhibits beta-catenin expression in normal-appearing colon of hereditary nonpolyposis colorectal cancer and familial adenomatous polyposis patients

AU - Koornstra, J.J.

AU - Rijcken, F.E.

AU - Oldenhuis, C.N.

AU - Zwart, N.

AU - van der Sluis, T.

AU - Hollema, H.

AU - de Vries, E.G.

AU - Keller, J.J.

AU - Offerhaus, G.J.A.

AU - Giardiello, F.M.

AU - Kleibeuker, J.H.

PY - 2005

Y1 - 2005

KW - Econometric and Statistical Methods: General

KW - Geneeskunde (GENK)

KW - Geneeskunde(GENK)

KW - Algemeen onderzoek

KW - Internal medicine

M3 - Article

SN - 1055-9965

VL - 14

SP - 1608

EP - 1612

JO - Cancer Epidemiology Biomarkers & Prevention

JF - Cancer Epidemiology Biomarkers & Prevention

IS - 7

ER -